Acumen Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Acumen Wealth Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11	Closed	-$992	–	586
2025 Q4	$992	Buy	+11	New	+$1.04K	﹤0.01%	450

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acumen Wealth Advisors's ZBH Position: Q1 2026 in Review

Acumen Wealth Advisors sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 11 shares — an estimated $992 sold.

Acumen Wealth Advisors first reported a position in ZBH in Q4 2025 and held it in 1 quarter. The position peaked at $992 in Q4 2025. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Acumen Wealth Advisors reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
Acumen Wealth Advisors sold 11 Zimmer Biomet shares in Q1 2026, an estimated $992.
Acumen Wealth Advisors first reported a position in Zimmer Biomet in Q4 2025 and held it in 1 quarter.
Acumen Wealth Advisors's Zimmer Biomet position peaked at $992 in Q4 2025.
916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Acumen Wealth Advisors's 13F filing for Q1 2026, filed 13 May 2026.